An Investigator Initiated, Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of Glycopyrrolate/Formoterol on Exercise Tolerance and Dynamic Hyperinflation in Patients With Chronic Obstructive Pulmonary Disease
Phase of Trial: Phase IV
Latest Information Update: 11 Oct 2019
Price : $35 *
At a glance
- Drugs Formoterol/glycopyrrolate (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 31 Jan 2019 Status changed from recruiting to completed.
- 22 Feb 2018 Planned End Date changed from 1 Dec 2018 to 31 Dec 2019.
- 22 Feb 2018 Planned primary completion date changed from 1 Dec 2018 to 31 Dec 2018.